Active Ingredient History
Nerve growth factor (NGF) is a neurotrophic factor and neuropeptide primarily involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons. It is perhaps the prototypical growth factor, in that it was one of the first to be described. Since it was first isolated by Nobel Laureates Rita Levi-Montalcini and Stanley Cohen in 1956, numerous biological processes involving NGF have been identified, two of them being the survival of pancreatic beta cells and the regulation of the immune system. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Keratitis (approved 2018)
Alzheimer Disease (Phase 4)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 4)
Cerebral Palsy (Phase 2)
Cerebral Small Vessel Diseases (Phase 4)
Corneal Diseases (Phase 1)
Corneal Ulcer (Phase 1/Phase 2)
Dementia, Vascular (Phase 4)
Diabetes Mellitus (Phase 1/Phase 2)
Dry Eye Syndromes (Phase 3)
Glaucoma (Phase 1)
Healthy Volunteers (Phase 1)
HIV Infections (Phase 2)
Hyperalgesia (Early Phase 1)
Ischemic Stroke (Phase 4)
Keratitis (Phase 4)
Macular Edema (Phase 2)
Mental Disorders (Phase 2)
Optic Nerve (Phase 1)
Pain (Early Phase 1)
Peripheral Nerve Injuries (Phase 1)
Peripheral Nervous System Diseases (Phase 2)
Retinitis Pigmentosa (Phase 2)
Speech Disorders (Phase 2)
Stroke (Phase 4)
Vision, Ocular (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
